DEERFIELD, Ill., and CHIPPENHAM UK, November 1, 2007 — Baxter International Inc. (NYSE: BAX) and Vectura Group plc (LSE: VEC) today announced publication of data in the November 2007 issue of Fertility and Sterility of the first randomized, double-blind trial of an adhesion reduction agent, ADEPT Adhesion Reduction Solution [4% Icodextrin Solution] in gynecological laparoscopic surgery compared to lactated Ringer’s solution (LRS). In one of the largest adhesion reduction agent trials performed, ADEPT was shown to be more effective than lactated Ringer’s solution (LRS) in reducing the incidence of post-operative adhesions in patients undergoing gynecological laparoscopic adhesiolysis. ADEPT was also found to be safe and in particular showed efficacy in infertility patients.
